CIK 0001035354 · Non-accelerated filer<br>Smaller reporting company
Eloxx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELOX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841368850
- Phone
- 781-577-5300
- Business address
- P.O. BOX 274, ARLINGTON, MA, 02476
- Former names
- Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-10-30 | Williams Gregory C. CHIEF EXECUTIVE OFFICER | Option exercise | +1,875 | 9,382 | ||
| 2020-10-30 | Williams Gregory C. CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −625 | $2.53 | $2K | 8,757 |
| 2020-10-30 | Williams Gregory C. CHIEF EXECUTIVE OFFICER | Option exercise · Restricted Stock Units | −1,875 | 16,875 | ||
| 2020-10-30 | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | Option exercise | +1,562 | 7,853 | ||
| 2020-10-30 | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | Shares withheld for taxes | −459 | $2.53 | $1K | 7,394 |
| 2020-10-30 | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | Option exercise · Restricted Stock Units | −1,562 | 14,063 | ||
| 2020-07-30 | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | Option exercise | +1,563 | 6,750 | ||
| 2020-07-30 | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | Shares withheld for taxes | −459 | $2.84 | $1K | 6,291 |
| 2020-07-30 | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | Option exercise · Restricted Stock Units | −1,563 | 15,625 | ||
| 2020-07-30 | Williams Gregory C. CHIEF EXECUTIVE OFFICER | Option exercise | +1,875 | 8,083 | ||
| 2020-07-30 | Williams Gregory C. CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −576 | $2.84 | $2K | 7,507 |
| 2020-07-30 | Williams Gregory C. CHIEF EXECUTIVE OFFICER | Option exercise · Restricted Stock Units | −1,875 | 18,750 | ||
| 2020-05-20 | Rubin Steven D Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-05-20 | Pontifax Management 4 G.P. (2015) Ltd. 10% owner | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-05-20 | Pontifax Management 4 G.P. (2015) Ltd. 10% owner | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-05-20 | Seehra Jasbir Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-05-20 | Veinrib Gadi Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-05-20 | Kariv Tomer Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-05-20 | Avnur Zafrira Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-05-20 | Noiman Silvia Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 |
Page 8 of 11 · 206 trades